A new-age for biologic therapies: Long-term drug free therapy with BiP?

by Adrian Matthew Shields, Gabriel ePanayi, Valerie eCorrigall
Published 2012-02-01

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

by Nicola J. Gullick, Fowzia Ibrahim, Ian C. Scott, Alexandra Vincent, Andrew P. Cope, Toby Garrood, Gabriel S. Panayi, David L. Scott, Bruce W. Kirkham, On behalf of TITRATE Programme Investigators
Published 2019-02-01

Binding Immunoglobulin Protein (BIP) Inhibits TNF‐α–Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model

by Mario M. Zaiss, Christopher Hall, Neil W. A. McGowan, Rebecca Babb, Vikesh Devlia, Sébastien Lucas, Sajeda Meghji, Brian Henderson, Aline Bozec, Georg Schett, Jean‐Pierre David, Gabriel S. Panayi, Agamemnon E. Grigoriadis, Valerie M. Corrigall
Published 2019-08-01